Thujone Inhibits Lung Metastasis Induced by B16F-10 Melanoma Cells in C57BL/6 Mice
Overview
Physiology
Authors
Affiliations
The antimetastatic potential of thujone, a naturally occurring monoterpene, was evaluated. Metastasis was induced in C57BL/6 mice by injecting highly metastatic B16F-10 melanoma cells through the lateral tail vein. Administration of thujone (1 mg·(kg body weight)(-1)), prophylactically and simultaneously with tumor induction, inhibited tumor nodule formation in the lungs by 59.45% and 57.54%, respectively, with an increase in the survival rate (33.67% and 32.16%) of the metastatic tumor bearing animals. These results correlated with biochemical parameters such as lung collagen hydroxyproline, hexosamine and uronic acid contents, serum sialic acid and γ-glutamyl transpeptidase levels, and histopathological analysis. Treatment with thujone downregulated the production of proinflammatory cytokines such as tumor necrosis factor-α, interleukin (IL)-1β, IL-6, and granulocyte-monocyte colony-stimulating factor. Thujone administration downregulated the expression of matrix metalloproteinase (MMP)-2, MMP-9, extracellular signal-regulated kinase (ERK)-1, ERK-2, and vascular endothelial growth factor (VEGF) and also upregulated the expression of nm-23, tissue inhibitor of metalloproteinase (TIMP)-1, and TIMP-2 in the lung tissue of metastasis-induced animals. Treatment with thujone inhibited the activity of MMP-2 and MMP-9 in gelatin zymographic analysis. Thujone treatment significantly inhibited the invasion of B16F-10 melanoma cells across the collagen matrix in a Boyden chamber. Thujone also inhibited the adhesion of tumor cells to collagen-coated microtire plate wells and the migration of B16F-10 melanoma cells across a polycarbonate filter in vitro. These results indicate that Thujone can inhibit the lung metastasis of B16F-10 cells through inhibition of tumor cell proliferation, adhesion, and invasion, as well as by regulating expression of MMPs, VEGF, ERK-1, ERK-2, TIMPs, nm23, and levels of proinflammatory cytokines and IL-2 in metastatic animals.
Biological Activities and Phytochemical Screening of Extracts with In Silico Approaches.
Younes K, Abouzied A, Alqarni S, Elkashlan A, Hussein W, Alhathal R Int J Mol Sci. 2025; 26(3).
PMID: 39940708 PMC: 11817169. DOI: 10.3390/ijms26030939.
Unlocking the mechanistic potential of for managing diabetic neuropathy and nephropathy.
Singh S, Singh T J Tradit Complement Med. 2025; 14(6):581-597.
PMID: 39850604 PMC: 11752125. DOI: 10.1016/j.jtcme.2024.04.009.
L. (Cupressaceae): Ethnobotany, Phytochemistry and Biological Activity.
Caruntu S, Ciceu A, Olah N, Don I, Hermenean A, Cotoraci C Molecules. 2020; 25(22).
PMID: 33228192 PMC: 7699608. DOI: 10.3390/molecules25225416.
Di Martile M, Garzoli S, Ragno R, Del Bufalo D Cancers (Basel). 2020; 12(9).
PMID: 32948083 PMC: 7565555. DOI: 10.3390/cancers12092650.
Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis.
Tomko A, Whynot E, Ellis L, Dupre D Cancers (Basel). 2020; 12(7).
PMID: 32708138 PMC: 7409346. DOI: 10.3390/cancers12071985.